Penbutolol
Clinical data | |
---|---|
Trade names | Levatol |
AHFS/Drugs.com | Consumer Drug Information |
MedlinePlus | a601091 |
ATC code | |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Penbutolol (brand names Levatol, Levatolol, Lobeta, Paginol, Hostabloc, Betapressin) is a
It was approved by the FDA in 1987[4] and was withdrawn from the US market by January 2015.[5]
Medical uses
Penbutolol is used to treat mild to moderate
It should not be used or only used with caution in people with heart failure and people with asthma. It may mask signs of low blood sugar in people with diabetes and it may mask signs of hyperthyroidism.[1]
Animal studies showed some signs of potential trouble for women who are pregnant, and it has not been tested in women who are pregnant. It is not known if penbutolol is secreted in breast milk.[1]
Side effects
Penbutolol has a low frequency of side effects.[1][7] These side effects include dizziness, light headedness, and nausea.[1][8]
Pharmacology
Pharmacodynamics
Penbutolol is able to bind to both beta-1 adrenergic receptors and
Blocking β adrenergic receptors decreases the heart rate and
Penbutolol acts on the β1 adrenergic receptors in both the heart and the kidney. When β1 receptors are activated by a catecholamine, they stimulate a coupled G protein which activates adenylyl to convert adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP). The increase in cAMP ultimately alters the movement of calcium ions in heart muscle and increases heart rate.[2]: 213–214 Penbutolol blocks this and decreases heart rate, which lowers blood pressure.[10]: 40
The ability of penbutolol to act as a
Like
Pharmacokinetics
Penbutolol is rapidly absorbed from the gastrointestinal tract, has a
Society and culture
Availability
Penbutolol was approved by the FDA in 1987.[4] In January 2015 the FDA acknowledged that the penbutolol was no longer marketed in the US, and determined that the drug was not withdrawn for safety reasons.[5]
References
- ^ a b c d e f FDA Penbutolol label Last updated Dec 2010
- ^ ISBN 9780071826419
- ^ S2CID 12950442.
- ^ a b FDA History NDA 018976
- ^ a b FDA notice in the Federal Register. Jan 9, 2015 Determination That TAGAMET (Cimetidine) Tablets and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
- ^ NICE Hypertension guidance Last updated 2013
- PMID 2658525.
- ^ S2CID 31794332.
- PMID 6123586.
- ISBN 9780387095523
- ISBN 9780781771559
- PMID 8093601.
- ISBN 9781597450805